Indoco Remedies Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
INDOCO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indoco Remedies Limited has submitted its financial results for the quarter and nine months ended December 31, 2025 to the stock exchange. The filing covers the company's Q3 FY26 earnings, which would typically include revenue, profit after tax, and segment performance details. The actual numerical results are not included in this brief submission notice. Shareholders should refer to the detailed financial results file separately filed with the exchange for full numbers, segment-wise breakdown, and management commentary.
This is a routine regulatory disclosure confirming timely submission of quarterly results. The actual impact on shareholders will depend on the specific numbers in the detailed results, which are not disclosed in this filing notice. Investors should review the full results document for revenue growth, margin trends, and profit performance.